Published on: May 2022
The market overview of specific antiviral drugs
Antiviral Medicines Due to the rising incidence rate of infectious diseases, the market size reached USD 48 billion in 2021 and is predicted to grow at a 3.4 percent CAGR through 2028. One of the major factors impacting the need for antiviral medications is the rising prevalence of HIV infections around the world. According to the United States Department of Health and Human Services and the Minority HIV/AIDS Fund, there will be roughly 37.7 million HIV infections worldwide in 2020. As a result, increased product accessibility for advanced therapies, such as antiretroviral therapy, in developed nations to address disease load will move the total antiviral medications market forward. Furthermore, according to World Health Organization estimates from 2019, over 1.5 million new instances of hepatitis B infection are recorded each year, with nearly 296 million people worldwide afflicted with chronic hepatitis B. As a result, the increased prevalence of various infectious disorders such herpes simplex virus, hepatitis virus, and influenza will boost market revenue.
Product approvals for new infectious diseases are increasing, which will have a beneficial impact on market trends
The antiviral medications industry is divided into two types: branded and generic. Through 2028, the branded pharmaceuticals market is expected to grow at a CAGR of 2.9 percent. The large size of the segment is due to the widespread use of effective branded pharmaceuticals and the availability of a wider range of products in developed markets. Furthermore, the high product pricing of patented drugs enables industry actors to maximise product-related income. Increasing research and development initiatives, as well as quick product approvals, will help to drive segment demand even faster. Furthermore, the increased use of freshly introduced branded products due to the high prevalence of newly emerging infectious diseases with no prior approved therapies would strengthen the overall market outlook during the forecast period.
Market segmentation for Specific Antiviral drugs
The market for COVID-19 Specific Antiviral Drugs Market Size, Status, and Forecast 2022-2028 is categorized by companies, geography (country), type, and application. Players, stakeholders, and other market participants who utilise the research as a resource will be able to gain an advantage in the global Specific Antiviral Drugs for COVID-19 Market Size, Status, and Forecast 2022-2028 market. For the period 2017-2028, the segmental analysis focuses on revenue and forecasts by Type and Application.
Coverage by Type
Coverage of the following applications
Why should you trust the Industry Data Analytics?
The research "Specific Antiviral Drugs for COVID-19 Market Size, Status, and Forecast 2022-2028 Market" examines the worldwide and regional markets, providing an in-depth look at the market's overall growth potential. Antiviral Drugs for COVID-19 Market Size, Status, and Forecast 2022-2028 Market offers a detailed analysis of company information, business summary, major drivers, restraints, regional opportunities, emerging trends, dynamics, and development potential. Specific Antiviral Drugs for COVID-19 Market Size, Status, and Forecast 2022-2028 market size, share, and future prospects by 2028 are also examined in the report. The research includes a business profile, product terms, production/sales capacity, revenue, price, and gross margin sales for the top industry players, as well as a complete assessment of the market's competitive landscape and extensive data on suppliers.
Grab this expert study from the Industry Data Analytics team to open the doors to your success